Lundbeckfond Invest A/S 13D/13G Filings for OnKure Therapeutics, Inc. (OKUR)

Lundbeckfond Invest A/S 13D and 13G filings for OnKure Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-06
9:09 pm
Purchase		 2024-12-31 13G OnKure Therapeutics, Inc.
OKUR		 Lundbeckfond Invest A/S 203,122
1.600%		 203,122increase
(New Position)		 Filing